Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A McCulloch

Showing results (611-620 of 635) with videos related to

Pageof 64
Sort By:
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
Cell|October 24, 2017
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease ResistanceStephan P Rosshart, Brian G Vassallo, Davide Angeletti, et al.
Nature Communications|December 21, 2018
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart diseaseVaibhav B Patel, Pavel Zhabyeyev, Xueyi Chen, et al.
Oncotarget|July 25, 2022
Predicting cancer immunotherapy response from gut microbiomes using machine learning modelsHai Liang, Jay-Hyun Jo, Zhiwei Zhang, et al.
Journal of the American Heart Association|May 21, 2013
Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expressionGazi S Hossain, Edward G Lynn, Kenneth N Maclean, et al.
Cancer Letters|August 11, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancersChi Ma, Joy A Awosika, Cecilia Monge, et al.
Pediatric Cardiology|March 12, 2020
Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular DysfunctionMichael A McCulloch, Ashwin K Lal, Kenneth Knecht, et al.
Pediatric Cardiology|January 22, 2022
Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular DystrophyKatheryn E Gambetta, Michael A McCulloch, Ashwin K Lal, et al.
Pediatric Transplantation|November 16, 2022
Fontan-associated liver disease after heart transplantEric R Griffiths, Linda M Lambert, Zhining Ou, et al.
Progress in Pediatric Cardiology|July 31, 2019
Use of advanced heart failure therapies in Duchenne muscular dystrophyCarol A Wittlieb-Weber, Chet R Villa, Jennifer Conway, et al.
Pageof 64

Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
Cell|October 24, 2017
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease ResistanceStephan P Rosshart, Brian G Vassallo, Davide Angeletti, et al.
Nature Communications|December 21, 2018
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart diseaseVaibhav B Patel, Pavel Zhabyeyev, Xueyi Chen, et al.
Oncotarget|July 25, 2022
Predicting cancer immunotherapy response from gut microbiomes using machine learning modelsHai Liang, Jay-Hyun Jo, Zhiwei Zhang, et al.
Journal of the American Heart Association|May 21, 2013
Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expressionGazi S Hossain, Edward G Lynn, Kenneth N Maclean, et al.
Cancer Letters|August 11, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancersChi Ma, Joy A Awosika, Cecilia Monge, et al.
Pediatric Cardiology|March 12, 2020
Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular DysfunctionMichael A McCulloch, Ashwin K Lal, Kenneth Knecht, et al.
Pediatric Cardiology|January 22, 2022
Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular DystrophyKatheryn E Gambetta, Michael A McCulloch, Ashwin K Lal, et al.
Pediatric Transplantation|November 16, 2022
Fontan-associated liver disease after heart transplantEric R Griffiths, Linda M Lambert, Zhining Ou, et al.
Progress in Pediatric Cardiology|July 31, 2019
Use of advanced heart failure therapies in Duchenne muscular dystrophyCarol A Wittlieb-Weber, Chet R Villa, Jennifer Conway, et al.
Pageof 64